Bio
Julie Lee is a board-certified internal medicine physician and clinical informaticist at Stanford University. Dr. Lee's expertise in clinical informatics enables her to use informatics-driven approaches and clinically integrate AI models to improve patient health outcomes, alleviate physician burnout by streamlining workflows, and champion health equity at all levels. Dr. Lee focuses on clinical feasibility of AI implementation in healthcare systems and also leveraging patient data and AI models to identify/mitigate health disparities, making certain they function as instruments of equity rather than increasing gaps.
Dr. Lee has been key to several initiatives in improving operational processes within Stanford. Her efforts include: 1) advancing the governance and operations of Clinical Decision Support, 2) strategic integration of the Prescription Drug Monitoring Program into the electronic health record (EHR) to address the opioid crisis 3) human factors analysis of the usability of health information technology on physicians and patient outcomes. Additionally, she has worked on innovative solutions to improve patient-physician communications--including the creation of a dynamic EHR tool for better triage and processing by medical staff before a medical advice request reaches the doctors.
Health equity is her north star, informing Dr. Lee to dedicated engagement with historically underrepresented populations in medical research and collaborative partnerships between academia and community healthcare practitioners. Her previous role as an EpiScholar with the Los Angeles Department of Public Health involved researching the impact of language and acculturation on the Latino population's dietary habits and health behaviors, with a particular focus on diabetes. She has also worked with community health centers in east Los Angeles to bridge the translational gap between academic research and frontline healthcare workers, facilitating the transfer of cutting-edge liver disease research to those treating patients with substance abuse-related liver conditions.
Of major clinical interest is cardiovascular disease—she has published several papers including a landmark article on the impact of sex-specific risk factors for cardiovascular disease in women and transgender population. She is interested in improving precision health for Asians and NHPI.
